Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
1.940
-0.010 (-0.51%)
Jun 6, 2025, 2:45 PM CST
Kangmei Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 894.14 | 977.84 | 1,057 | 1,507 | 2,419 | 552.34 | Upgrade
|
Trading Asset Securities | 0.08 | 0.08 | 0.08 | 0.12 | 0.52 | - | Upgrade
|
Cash & Short-Term Investments | 894.22 | 977.92 | 1,057 | 1,508 | 2,419 | 552.34 | Upgrade
|
Cash Growth | 20.07% | -7.45% | -29.90% | -37.68% | 337.98% | 8.93% | Upgrade
|
Accounts Receivable | 2,514 | 2,542 | 2,249 | 2,046 | 1,460 | 2,487 | Upgrade
|
Other Receivables | 659.92 | 823.86 | 874.44 | 888.79 | 1,052 | 9,559 | Upgrade
|
Receivables | 3,174 | 3,366 | 3,123 | 2,935 | 2,512 | 12,046 | Upgrade
|
Inventory | 2,512 | 2,510 | 2,644 | 2,751 | 3,195 | 5,709 | Upgrade
|
Prepaid Expenses | - | - | - | 0 | - | 0.01 | Upgrade
|
Other Current Assets | 313.15 | 45.65 | -14.11 | 190.85 | 158.8 | 234.39 | Upgrade
|
Total Current Assets | 6,894 | 6,900 | 6,810 | 7,384 | 8,285 | 18,541 | Upgrade
|
Property, Plant & Equipment | 3,454 | 3,500 | 3,875 | 4,180 | 4,642 | 9,603 | Upgrade
|
Long-Term Investments | 1.11 | 1.11 | 1.15 | 1.39 | 1 | 1 | Upgrade
|
Goodwill | 106.35 | 106.35 | 106.35 | 106.35 | 106.35 | 36.91 | Upgrade
|
Other Intangible Assets | 404.86 | 409.47 | 491.02 | 529.79 | 579.73 | 1,309 | Upgrade
|
Long-Term Deferred Tax Assets | 71.03 | 74.36 | 101.48 | 96.97 | 60.69 | 240.96 | Upgrade
|
Long-Term Deferred Charges | 51.08 | 55.05 | 66.47 | 86.71 | 110.22 | 111.57 | Upgrade
|
Other Long-Term Assets | 2,732 | 2,752 | 2,829 | 2,783 | 2,269 | 3,483 | Upgrade
|
Total Assets | 13,714 | 13,798 | 14,280 | 15,169 | 16,054 | 33,326 | Upgrade
|
Accounts Payable | 2,505 | 2,546 | 2,256 | 2,563 | 2,015 | 3,762 | Upgrade
|
Accrued Expenses | 49.21 | 520.42 | 716.97 | 1,328 | 1,134 | 2,066 | Upgrade
|
Short-Term Debt | 33 | 15.83 | 26.14 | 25.62 | 15.17 | 2,315 | Upgrade
|
Current Portion of Leases | 25.73 | 28.35 | 40.71 | 39.12 | 36.89 | - | Upgrade
|
Current Income Taxes Payable | 414.99 | 27.7 | 24.74 | 26.2 | 140.5 | 112.15 | Upgrade
|
Current Unearned Revenue | 140.22 | 118.82 | 159.89 | 158.12 | 193.85 | 455.19 | Upgrade
|
Other Current Liabilities | 2,650 | 2,637 | 2,875 | 1,301 | 1,411 | 14,576 | Upgrade
|
Total Current Liabilities | 5,818 | 5,894 | 6,100 | 5,442 | 4,947 | 23,286 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 19,415 | Upgrade
|
Long-Term Leases | 87.91 | 94.95 | 188.16 | 199.13 | 153.22 | - | Upgrade
|
Long-Term Unearned Revenue | 547.64 | 555.78 | 618.68 | 653.98 | 692.97 | 1,035 | Upgrade
|
Long-Term Deferred Tax Liabilities | 24.71 | 26.85 | 51.68 | 55.53 | - | 0.05 | Upgrade
|
Other Long-Term Liabilities | 17.79 | 17.79 | 241.31 | 1,835 | 293.02 | - | Upgrade
|
Total Liabilities | 6,496 | 6,589 | 7,200 | 8,185 | 6,086 | 43,736 | Upgrade
|
Common Stock | 13,864 | 13,864 | 13,864 | 13,864 | 13,864 | 4,974 | Upgrade
|
Additional Paid-In Capital | 18,783 | 18,783 | 18,783 | 18,783 | 18,783 | 11,576 | Upgrade
|
Retained Earnings | -24,358 | -24,367 | -24,375 | -24,478 | -21,790 | -29,706 | Upgrade
|
Treasury Stock | -1,107 | -1,107 | -1,225 | -1,222 | -932.82 | -343.6 | Upgrade
|
Comprehensive Income & Other | 1.19 | 1.18 | 1.18 | 1.43 | 3.1 | -3.74 | Upgrade
|
Total Common Equity | 7,183 | 7,174 | 7,048 | 6,948 | 9,927 | -13,504 | Upgrade
|
Minority Interest | 35.01 | 34.55 | 32.89 | 35.43 | 41.92 | 126.47 | Upgrade
|
Shareholders' Equity | 7,218 | 7,209 | 7,080 | 6,984 | 9,968 | -10,410 | Upgrade
|
Total Liabilities & Equity | 13,714 | 13,798 | 14,280 | 15,169 | 16,054 | 33,326 | Upgrade
|
Total Debt | 146.65 | 139.13 | 255.01 | 263.87 | 205.29 | 21,730 | Upgrade
|
Net Cash (Debt) | 747.57 | 838.8 | 801.68 | 1,244 | 2,214 | -21,178 | Upgrade
|
Net Cash Growth | 52.95% | 4.63% | -35.54% | -43.82% | - | - | Upgrade
|
Net Cash Per Share | 0.05 | 0.06 | 0.08 | 0.09 | 0.16 | -1.53 | Upgrade
|
Filing Date Shares Outstanding | 13,864 | 13,864 | 13,864 | 13,864 | 13,864 | 4,974 | Upgrade
|
Total Common Shares Outstanding | 13,864 | 13,864 | 13,864 | 13,864 | 13,864 | 4,974 | Upgrade
|
Working Capital | 1,076 | 1,007 | 709.67 | 1,942 | 3,338 | -4,745 | Upgrade
|
Book Value Per Share | 0.52 | 0.52 | 0.51 | 0.50 | 0.72 | -2.71 | Upgrade
|
Tangible Book Value | 6,672 | 6,658 | 6,450 | 6,312 | 9,240 | -14,849 | Upgrade
|
Tangible Book Value Per Share | 0.48 | 0.48 | 0.47 | 0.46 | 0.67 | -2.99 | Upgrade
|
Buildings | - | 5,119 | 5,229 | 5,401 | 5,665 | 8,359 | Upgrade
|
Machinery | - | 1,162 | 1,162 | 826.65 | 1,206 | 2,799 | Upgrade
|
Construction In Progress | - | 175.32 | 210.56 | 215.5 | 263.65 | 1,630 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.